Thank you for sharing!

Your article was successfully shared with the contacts you provided.

The Mylan Laboratories Inc. headquarters in Canonsburg, Pennsylvania.The Mylan Laboratories Inc. headquarters in Canonsburg, Pennsylvania. (Jason Cohn/Getty)

A new year brings a new deal for Mylan NV. After thwarted tie-ups last year with Teva Pharmaceutical Industries Ltd. and Perrigo Co. PLC, global generics giant Mylan said Wednesday that it will acquire Meda AB of Sweden for $7.2 billion. Including debt, the cash-and-stock deal is valued at $9.9 billion.

Cravath, Swaine & Moore has taken the lead for Mylan on its deal for Meda, along with leading Swedish firm Vinge and top Dutch shop NautaDutilh. Cravath previously advised Mylan in 2007 on its $6.6 billion acquisition of Merck KGaA’s worldwide generic drug business.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.